We are strong communicators and ensure you have as much relevant information at your fingertips as possible.

Press release

Stiris Research Inc. Awarded Global Hereditary Angioedema Trial

February 15, 2024
Press release

Stiris Research Inc. Announces First Site Activated Phase Ib Amyotrophic Lateral Sclerosis Study

December 19, 2023
Press release

Stiris Research Inc. Announces the First Patient Treated In Non-Small Cell Lung Cancer Trial

December 14th, 2023
Press release

Stiris Research Inc. Announces the First Site Initiated in Phase II Amyotrophic Lateral Sclerosis Trial

December 4th, 2023
Press release

Stiris Research Inc. Announces the First Site Initiated In Phase I Non-Small Cell Lung Cancer Trial

November 8th, 2023
Press release

Stiris Research Inc. Announces Database Lock in Phase II Hepatorenal-Syndrome Trial

November 2nd, 2023
Press release

A Deep Dive into the ICH GCP Revision 3: Unpacking the Digital Implications

July 27, 2023
Press release

Stiris Research Inc. Awarded Phase II Amyotrophic Lateral Sclerosis Trial

May 12th, 2023
Press release

Stiris Research Inc. Announces First Patient Enrolled in Phase II Hepatorenal-Syndrome Trial

February 20, 2023
Press release

Stiris Research Inc. Awarded Phase III Glioblastoma Study

February 17, 2023
Press release

Stiris Research Inc. Awarded  Phase I Non-Small Cell Lung Cancer Trial

January 24, 2023
Press release

Stiris Research Inc. Announces First Treatment-Naive Subject Screening in Phase II-III Congenital Myotonic Dystrophy Trial.

January 9, 2023
Press release

Stiris Research Inc. Announces Recruitment Closed in Phase II-III Congenital Myotonic Dystrophy Trial

November 22, 2022
Press release

Stiris Research Inc. Announces Successful Enrollment Completion in Phase II Retinal Vein Occlusion Study 

November 16, 2022
Press release

Stiris Research Announces Completion of the Multiple Year Smallpox Vaccine Study

August 31, 2022
Press release

Stiris Research Inc. Announces First Patient Dosed in Phase II Retinal Vein Occlusion Study

August 25, 2022
Press release

Stiris Research Inc. Awarded Rescue Study for Hepatorenal-Syndrome

August 8, 2022
Press release

Stiris Research Inc. Awarded Phase I Metastatic Resistant Prostate Cancer Trial with Bone Metastasis Trial

July 22nd, 2022
Press release

Stiris Research Announces Positive Results from Zucara Therapeutics’ Phase 1b Hypoglycemic Clamp Trial

June 22, 2022
Press release

Stiris Research Inc. Announces First Patient Treated in Study Using Artificial Intelligence (AI) in Patients with Depression

June 17, 2022
Press release

Stiris Research Announces Database Lock in Phase 1b Hypoglycemic Clamp Trial

May 25, 2022
Press release

Stiris Research Inc. Announces the Addition of Fernando Lasso de la Vega, MD to the Clinical Science Team.

April 11, 2022
Press release

Stiris Research Inc. Awarded Pivotal Pre-Hospital Cardiovascular Study

March 17, 2022
Press release

Stiris Research Inc. Announces Enrollment of First Patient in Paraoxysmal Nocturnal Hemoglobinuria Study.

March 4, 2022
Press release

Stiris Research Inc. Announces First Site Initiated in Study Using Artificial Intelligence (AI) in Patients with Depression

December 17, 2021
Press release

Stiris Research Inc. Announces the First Site Initiated in Paraoxysmal Nocturnal Hemoglobinuria Studies

November 17, 2021
Press release

Stiris Research Announces First Site Initiated in COVID-19 Rescue Study

November 16, 2021
Press release

Stiris Research Inc. Announces Successful Completion of Clinical Study Report for a Phase IB Study in Uveal Melanoma

October 13th, 2021
Press release

Stiris Research Inc. Announces Award of Proof-Of-Concept Study for Agitation in Autism Spectrum Disorder

October 2021
Press release

Stiris Research Inc. Announces First Site Initiation in Phase II-III Congenital Myotonic Dystrophy Trial

August 22, 2021
Press release

Stiris Research Inc. Announces First Patient Enrolled in Phase II-III Congenital Myotonic Dystrophy Trial

August 3, 2021
Press release

Stiris Research Announces Completion of Patient Visits in Smallpox Study

August 2021
Press release

Stiris Research Inc. Announces First Patients Dosed in Zucara’s Phase 1b Hypoglycemic Clamp Trial

July 28, 2021
Press release

Stiris Research Announces Site Initiated in Zucara’s Phase 1b Hypoglycemic Clamp Trial

June 29, 2021
Press release

Stiris Research Inc. Celebrates International Women’s Day

March 8, 2021
Press release

Stiris Research Inc. Awarded Rescue Study in COVID-19 Program

February 4, 2021
Press release

Stiris Research Inc. Awarded Phase I Clamp trial in Type 1 Diabetes Mellitus

January 12, 2021
Press release

Stiris Research Inc. Awarded 2 Global Rare Disease Studies

November 30, 2020
Press release

Stiris Research Inc. Awarded a Phase 2 Nephropathy Study

17 November 2020
Press release

Stiris Research Inc. Phase I Study in COVID-19

23 October 2020
Press release

Stiris Research Inc. Announces First Subjects Dosed

September 23, 2020
Press release

Stiris Research Inc. Phase I Healthy Volunteer Study in COVID-19

21 September 2020
Press release

Stiris Research Inc. Awarded a Pilot Study Using Artificial Intelligence (AI) in Patients with Depression

14 September 2020
Press release

Stiris Research Inc. Awarded First-in-Human, Phase I clinical trial in Type 1 Diabetes Mellitus

July 14, 2020
Press release

WEBINAR RECORDING – Centralizing Clinical Trial Activities: Can this be the New Norm?

May 27, 2020
Press release

Helping The Community During COVID-19

May 15, 2020
Press release

How are you managing stress during a global pandemic & physical distancing? The Stiris Team wants to help.

April 22, 2020
Press release

A CRA’s Perspective on Keeping Sites Engaged During COVID-19

April 16, 2020
Press release

Finding Your Feet in the Clinical Trials World During a Global Pandemic

April 13, 2020
Press release

Managing Newly Remote Teams During a Global Crisis

April 6, 2020
Press release

Stiris Research Inc. completes Phase IIa Venous Leg Ulcer Study

January 16, 2020
Press release

Stiris Research Inc. Announces Collaboration With US Biotech Company On Their Neurological Movement Disorder Trial

November 6, 2019
Press release

Stiris Research Inc. announces addition of a Director, Clinical Science

May 13, 2019
Press release

Stiris Research Inc. successful completion of their Zika Virus trial

March 6, 2019
Press release

Press Release – Stiris’ Shantal Feltham Receives YMCA Women of Excellence in Entrepreneurship

February 8, 2019
Press release

Stiris Research Inc. completes enrollment ahead of schedule on a Phase 1b Uveal Melanoma study

January 14, 2019
Press release

Stiris Research Inc. announces favourable FDA response on US pancreatic cancer program

December 18, 2018
Press release

Stiris Research Inc. collaborates with Canadian biotech to research a novel cancer therapy guidance tool

August 3, 2018
Press release

Stiris Research Inc. announces completion of Site Closeout Visits in their Phase II Hormone Refractory Castrate-Resistant Prostate Cancer (HRCPC) study

May 24, 2018
Press release

Stiris Research Inc. announces continued collaboration with North American biotechnology company on their Zika Virus trial

May 2, 2018
Press release

Stiris Research Inc. announces the completion of Site Closeout Visits for its Phase III trial in Parkinson’s Disease

March 23, 2018
Press release

Stiris Research Inc. hits corporate target of First Patient treated on US pancreatic cancer program

March 22, 2018
Press release

Stiris Research Inc. completes database lock on Phase III Global Parkinson’s trial

February 22, 2018
Press release

Stiris Research Inc. hits corporate target of First Patient First Visit on Phase 1b Uveal Melanoma study

February 2, 2018
Press release

Stiris Research Inc. announces First Site Initiation on Phase II Frontotemporal Dementia Study

January 24, 2018
Press release

Stiris Research Inc. awarded Phase Ib trial in Uveal Melanoma

November 7, 2017
Press release

Stiris Research Inc. completes Phase II Meniere’s disease study

September 26, 2017
Press release

Stiris Research Inc. collaborates on a Investigator Initiated Trial in Frontotemporal Dementia

August 17, 2017
Press release

Stiris Research’s CEO Shantal Feltham Voted #10 In Canada’s 15 Most Influential Female Entrepreneurs

August 2, 2017
Press release

Stiris Research Inc. awarded a Phase I Healthy Volunteer study in Parkinson’s disease

July 28, 2017
Press release

Stiris Research Inc. awarded extension of Phase II Hormone Refractory Castrate-Resistant Prostate Cancer (HRCPC) study

July 17, 2017
Press release

Stiris Research Inc. hits corporate target of First Patient Visit in a Phase III Global Parkinson’s Study

April 10, 2017
Press release

Stiris Research Inc. awarded a Phase IIa Venous Leg Ulcer Study

April 3, 2017
Press release

Stiris Research Inc. collaborates with US biotech to conduct preliminary feasibility in Non-Hodgkin’s Lymphoma

April 2, 2017
Press release

Stiris Research Inc. hits corporate target of First Site Initiation Visit in a Phase III Global Parkinson’s Study

February 28, 2017
Press release

Stiris Research Inc. completes database lock on Phase III Global Parkinson’s trial

February 22, 2017
Press release

Stiris Research Inc. exceeds recruitment targets in Phase II Meniere’s disease study

October 31, 2016
Press release

Stiris Research Inc. collaborates with US biotech to conduct their Phase III Global Parkinson’s Study

October 17, 2016
Press release

Stiris Ranks 124th on the 2016 PROFIT 500

September 15, 2016
Press release

Stiris Research’s CEO Ranks No. 9 on the W100

May 16, 2021
Press release

Stiris Research’s CEO Selected for Elite Ivey Program

May 8, 2016
Press release

Stiris Ranks 23rd on Profit/Chatelaine W100

May 21, 2015